← Open Payments lookup

BESSY MARTIROSYAN: Open Payments

NPI 1790849883 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$402 in 17 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $255 · 2025 $402

Food & beverage: $402
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$133
E.R. Squibb & Sons, L.L.C.3$82
Supernus Pharmaceuticals, Inc.3$67
Alkermes, Inc.2$50
Abbott Laboratories1$26
Axsome Therapeutics, Inc.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: COBENFY, Qelbree, ABILIFY ASIMTUFII, ARISTADA, ABILIFY MAINTENA, REXULTI, MITRACLIP, Auvelity.

Industry payments across CA — which companies pay providers there.